Tarsus Pharmaceuticals In...

NASDAQ: TARS · Real-Time Price · USD
54.99
0.85 (1.57%)
At close: Aug 15, 2025, 12:49 PM

Tarsus Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
94.82M 224.95M 71.66M 171.33M
Short-Term Investments
196.56M 2.5M 145.37M 483K
Long-Term Investments
3M 631K 371K 663K
Other Long-Term Assets
6.09M 1.51M 585K 463K
Receivables
48.06M 17.71M 3.58M 92K
Inventory
2.62M 3.11M 4.76M n/a
Other Current Assets
n/a n/a n/a 4.04M
Total Current Assets
356.7M 256.13M 225.38M 175.95M
Property-Plant & Equipment
2.87M 3.35M 1.53M 1.83M
Goodwill & Intangibles
8.33M 3.87M n/a n/a
Total Long-Term Assets
20.29M 9.36M 2.49M 2.96M
Total Assets
376.99M 265.49M 227.86M 178.91M
Account Payables
27.74M 18.15M 5.5M 2.86M
Deferred Revenue
n/a n/a n/a 697K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
48.95M 5.14M 3.69M 55K
Total Current Liabilities
80.61M 36.94M 15.43M 11.48M
Long-Term Debt
71.84M 29.82M 19.43M n/a
Other Long-Term Liabilities
n/a 233K 100K 114K
Total Long-Term Liabilities
71.84M 31.57M 19.53M 699K
Total Liabilities
152.46M 68.5M 34.96M 12.18M
Total Debt
72.45M 31.73M 20.16M 1.89M
Common Stock
6K 5K 5K 4K
Retained Earnings
-360.21M -244.66M -108.76M -46.67M
Comprehensive Income
179K -2K -74K n/a
Shareholders Equity
224.53M 196.99M 192.9M 166.73M
Total Investments
199.56M 3.13M 145.74K 483K